Chakraborty , P. ., & Chakraborty , K. . (2022). Anti-fibrotic agents could be the game-changer for post-COVID-19 pulmonary fibrosis treatment. European Journal of Biological Research, 12(1), 1–10. Retrieved from http://jbrodka.com/index.php/ejbr/article/view/1